SeaStar Medical Receives FDA Approval to Begin Study with
Patient enrollment in pivotal clinical study expected to begin in March DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a...
Source: globenewswire.com
Stay updated with breaking news from Cytopheretic Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patient enrollment in pivotal clinical study expected to begin in March DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a...
19.09.2022 - Denver, Colo. and Tampa, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) - SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, ... Seite 1
Dr. Chung is a renowned critical care physician, research and thought leader in extracorporeal life support therapies...